GSE Solutions Receives New Contracts for Continued Engineering Services
Get Alerts GVP Hot Sheet
Join SI Premium – FREE
One contract awarded in the
Much of the proceeds from these contracts will provide ASME Code Program updates for
Both new contracts include Appendix J License Amendments, In-Service Testing (IST) service updates, and training courses, which can be delivered virtually or onsite. These services will ensure our clients remain compliant with the requirements of the latest approved edition addenda of the ASME OM and ASME Section XI Codes and associated regulatory requirements.
"For over 20 years, GSE Programs & Performance (formerly True North Consulting) has provided a full range of engineering programmatic services to the nuclear industry," said
ABOUT GSE SOLUTIONS
Proven by more than 50 years of experience in the nuclear power industry, GSE knows what it takes to help customers deliver carbon-free electricity safely and reliably. Today, GSE Solutions leverages top talent, expertise, and technology to help energy facilities achieve next-level power plant performance. GSE's advanced Engineering and Workforce Solutions divisions offer highly specialized training, engineering design, program compliance, simulation, and technical staffing that reduce risk and optimize plant operations. With more than 1,100 installations and hundreds of customers in over 50 countries, GSE delivers operational excellence. www.gses.com
Media Contact
[email protected]
P: +1 410.970.7931
Investor Contact
Vice President
Lytham Partners
[email protected]
Direct: +1 646.829.9702
View original content to download multimedia:https://www.prnewswire.com/news-releases/gse-solutions-receives-new-contracts-for-continued-engineering-services-301970986.html
SOURCE GSE Systems, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Implantica announces successful completion of first RefluxStop® procedures in the U.S.
- Harbour BioMed Appoints Ms. Vivian Feng as Head of External Collaboration
- Acepodia Announces First Patient Dosed in Phase 1 Trial of ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share